Financial statements Inbiosens

Balance sheet of Inbiosens

Company age:
Age:
7 y. 11 m. 2 d.
Share capital:
Share capital:
10 000 PLN

Balance sheet data of INBIOSENS

Year
2017
2019
2022
2023
Total assets 6 420,04 3 132,73 12 032,79 15 271,01
A. Fixed assets 0,00 0,00 0,00 0,00
B. Current assets 6 420,04 3 132,73 12 032,79 15 271,01
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00
Total liabilities 6 420,04 3 132,73 12 032,79 15 271,01
A. Equity 4 402,84 290,33 -14 208,00 -20 580,86
B. Liabilities and provisions for liabilities 2 017,20 0,00 26 240,79 35 851,87
I. Long-term liabilities 0,00 0,00 0,00 33 484,12
II. Short-term liabilities 2 017,20 2 842,40 26 240,79 2 367,75
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.